COMP <GO>
DOCS vs SAIC // EV/EBITDA & P/E VALUATION
Doximity Inc. (NYSE) VS. Science Applications International Corporation (NASDAQ) • 15-METRIC TALLY: DOCS 7
— SAIC 7
▲ EV/EBITDA & P/E VALUATION LEADER: SAIC
LAST: $32.76 (-2.59%) • MKT CAP: $5.99B
valuation
27.9x
LAST: $151.86 (+0.67%) • MKT CAP: $6.32B
valuation
15.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOCS VS. SAIC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOCS | SAIC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 89.10% | 12.00% | +77.10 | DOCS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.20% | 10.90% | +6.30 | DOCS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 27.9x | 15.7x | +12.20 | SAIC | /valuation <GO> |
| Free Cash Flow Yield | 5.45% | 9.13% | -3.68 | SAIC | /fcf-yield <GO> |
| Operating Margin | 33.30% | 7.20% | +26.10 | DOCS | /operating-margins <GO> |
| Net Profit Margin | 30.40% | 4.90% | +25.50 | DOCS | /net-margins <GO> |
| Revenue Growth (YoY) | 13.10% | -2.90% | +16.00 | DOCS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.11% | -1.11 | SAIC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.31 | 3.59 | +18.72 | DOCS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | DOCS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 74.8 | -9.40 | SAIC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.25 | 1.40 | -0.15 | SAIC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.7x | 16.5x | +9.20 | SAIC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $6.32B | -$325.8M | SAIC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOCS REV | SAIC REV | DOCS GROSS % | SAIC GROSS % | DOCS FCF | SAIC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $644.9M | $7.26B | 89.1% | 12.0% | $326.5M | $577.0M |
| FY 2024 | $570.4M | $7.48B | 90.2% | 11.9% | $273.3M | $458.0M |
| FY 2023 | $475.4M | $7.44B | — | — | $162.7M | $61.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOCS // BETA 1.25
SAIC // BETA 1.40